An unexpected shot of bad news. A popular weight-loss shot has been recalled across the country by the FDA due to potential contamination. The US-based compounding pharmacy that issued the initial recall back in September had already been on the agency’s radar and previously received a warning. Apothecary Pharma is recalling compounded versions of popular … Read more
A costly jab. As more information is coming to light about one of the newest’s weight loss drug, the FDA’s Adverse Event Reporting System received reports of two deaths from bootleg versions of the medication. The products claimed to be the super-effective drug that’s nearing the end of clinical trials but has yet to be … Read more
A Maryland man claims that a popular weight-loss drug caused his total vision loss, leaving him legally blind. Todd Engel, 63, was first prescribed Ozempic in 2023 to help manage his diabetes. The GLP-1 medication, which is approved to treat type 2 diabetes, is also commonly prescribed off-label for weight loss. Approximately four months after … Read more
Weight loss drugs may do more than melt away pounds — they could melt away years. Pharmaceutical companies and makers of GLP-1 medications, Eli Lilly and Novo Nordisk, say the blockbuster drugs can slow biological aging. The notable difference in reversed aging adds evidence that the jabs and pills might be a true longevity treatment. … Read more
Ozempic and Mounjaro can cost an arm and a leg — and maybe a fingernail. A new study found that people on GLP-1 drugs were nearly 25% more likely to experience a nail disorder than those not on the drugs. And one particularly squirm-inducing problem was over four times more likely to appear in GLP-1 … Read more
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11% — meaning more than one in 10 adults are on one form or another of the jab. This explosion in use of drugs like Ozempic, Wegovy and Mounjaro has happened over a very short time — about … Read more
Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells, and a new study shows that it was effective in slimming down participants’ waistlines. Early data suggests it’s effective at keeping it off, too. The new drug targets subcutaneous and visceral fat around the belly. Dmytro Flisak … Read more
We’re learning more about the super-effective “triple-G” weight loss drug retatrutide. The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year. People are already clamoring to get their … Read more
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was getting worse by the day. He desperately tried to nail down the cause quickly, but his vision loss deteriorated even … Read more
As Americans increasingly turn to GLP-1 medications — which have been linked to a loss of lean muscle, especially during rapid weight loss — experts say preserving strength and mobility should be a priority as people age. Jacob Zemer, a New York-based fitness coach who primarily trains clients ranging from 35 to 55 years old, … Read more
As interest in peptides continues to grow, experts are increasingly looking beyond weight loss to their potential role in healthy aging. Functional medicine expert Dr. Will Cole told Fox News Digital that peptides are “intimately connected” with longevity, cellular healing and metabolic health. “[Peptides] help with cellular communication,” said Cole, co-author of the upcoming book … Read more
As GLP-1 medications continue reshaping the treatment of obesity and diabetes, researchers are also investigating whether the drugs could influence cancer risk and outcomes. The American Association for Cancer Research’s 2026 Cancer Progress Report, released earlier this month, noted that obesity is a major risk factor for many cancers. As glucagon-like peptide-1 medications – including … Read more
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that the medications caused NAION (nonarteritic anterior ischemic optic neuropathy), according to The Wall Street Journal. NAION is a rare eye condition in which … Read more
The latest findings about GLP-1s may leave you feeling queasy. These blockbuster weight-loss and diabetes treatments have exploded in popularity in recent years, with about one in eight US adults saying they were taking a medication like Ozempic or Wegovy in late 2025. Now, new research suggests patients taking GLP-1s could face an increased risk … Read more
A nurse who was diagnosed with infertility is pregnant with her third baby in two years after taking weight loss jabs to boost her chances of conception. Areli Ruiz, 35, and her husband Jose Ruiz, 34, refused to give up after being told by doctors she couldn’t conceive and she began taking Ozempic to reduce … Read more
McDonald’s shares dropped by more than 5% during its investor day presentation after CEO Chris Kempczinski said the company’s growth will be flat while inflation continues to accelerate. The burger giant on Wednesday outlined key details of a multi-year $8.5 billion investment to revamp its restaurants, make its menu tastier and upgrade technology, including an … Read more
It was the modern version of an indecent proposal. Shaylee Meurer, a 36-year-old plus-size influencer, once received a shocking offer from a major pharmacy brand: Take a popular GLP-1 drug for free, post about it on social media and reap a $7,000 reward. The big-time bid came at a vulnerable time for the content creator, … Read more
The scale may go down, but it doesn’t always stay there. About 1 in 8 American adults now says they’ve used GLP-1 drugs such as Ozempic and Wegovy to lose weight or manage a chronic condition. But many also stop using them — and often regain the weight. “It came back with taxes,” said Pamela … Read more
Two common GLP-1 weight loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly. More than one in 10 American adults are now on GLP-1s for weight loss. And while the jabs work to shed pounds and provide a host of other unexpected benefits, they can come … Read more
Don’t brush off this information. More than 80% of men and women experience some pattern hair loss during their lifetime, according to NYU Langone. And while no single special potion or medical device completely reverses loss of locks due to genetics or age, not all hope is lost when it comes to balding. Dr. Kseniya … Read more